Terms: = Leukemia AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Prognosis
28 results:
1. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
[TBL] [Abstract] [Full Text] [Related]
2. High caspase 3 and vulnerability to dual BCL2 family inhibition define eto2::GLIS2 pediatric leukemia.
Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical Efficacy of ALL-2005 and ALL-2009 Regimen and Factors Influencing prognosis of Newly Diagnosed ALL Patients Aged between 10-18 Years Old].
Li X; Si SY; Cai JJ; Qu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1904-1911. PubMed ID: 33283718
[TBL] [Abstract] [Full Text] [Related]
4. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
[TBL] [Abstract] [Full Text] [Related]
5. Second cancers in MPN: Survival analysis from an international study.
Marchetti M; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Cacciola R; McMullin MF; Tieghi A; Recasens V; Isfort S; Pane F; De Stefano V; Griesshammer M; Alvarez-Larran A; Vannucchi AM; Rambaldi A; Barbui T
Am J Hematol; 2020 Mar; 95(3):295-301. PubMed ID: 31816122
[TBL] [Abstract] [Full Text] [Related]
6. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
Flach J; Shumilov E; Joncourt R; Porret N; Tchinda J; Legros M; Scarpelli I; Hewer E; Novak U; Schoumans J; Bacher U; Pabst T
Genes Chromosomes Cancer; 2020 Apr; 59(4):268-274. PubMed ID: 31756777
[TBL] [Abstract] [Full Text] [Related]
7. Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT.
Borrow J; Dyer SA; Akiki S; Griffiths MJ
Blood; 2019 Dec; 134(25):2291-2303. PubMed ID: 31650162
[TBL] [Abstract] [Full Text] [Related]
8. Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in leukemia and Other Cancers.
Jetten AM
Trends Cancer; 2019 Sep; 5(9):547-557. PubMed ID: 31474360
[TBL] [Abstract] [Full Text] [Related]
9. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid leukemia: A Report from the Children's Oncology Group.
Pardo LM; Voigt AP; Alonzo TA; Wilson ER; Gerbing RB; Paine DJ; Dai F; Menssen AJ; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Brodersen LE; Loken MR
Cytometry B Clin Cytom; 2020 Jan; 98(1):52-56. PubMed ID: 31294507
[TBL] [Abstract] [Full Text] [Related]
10. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
[TBL] [Abstract] [Full Text] [Related]
11. Myeloid translocation gene cbfa2t3 directs a relapse gene program and determines patient-specific outcomes in AML.
Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
[TBL] [Abstract] [Full Text] [Related]
12. [Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia].
Liu XJ; Huang XJ; Xu LP; Liu KY; Zhang XH; Yan CH; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):182-186. PubMed ID: 30929382
[No Abstract] [Full Text] [Related]
13. [Pediatric de novo acute megakaryoblastic leukemia: an affair of complexes].
Lopez CK; Mercher T
Med Sci (Paris); 2018 Nov; 34(11):954-962. PubMed ID: 30526836
[TBL] [Abstract] [Full Text] [Related]
14. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
Shiba N
Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
[TBL] [Abstract] [Full Text] [Related]
15. Impact of clinical utility of MRD assessment with different techniques on survival in acute B lymphoblastic leukemia.
Huang A; Huang C; Tang G; Cheng H; Liu M; Ding J; Gong S; Chen Q; Zhang W; Yang J; Wang J; Hu X
Leuk Lymphoma; 2018 May; 59(5):1073-1083. PubMed ID: 28857648
[TBL] [Abstract] [Full Text] [Related]
16. eto2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic leukemia.
Thirant C; Ignacimouttou C; Lopez CK; Diop M; Le Mouël L; Thiollier C; Siret A; Dessen P; Aid Z; Rivière J; Rameau P; Lefebvre C; Khaled M; Leverger G; Ballerini P; Petit A; Raslova H; Carmichael CL; Kile BT; Soler E; Crispino JD; Wichmann C; Pflumio F; Schwaller J; Vainchenker W; Lobry C; Droin N; Bernard OA; Malinge S; Mercher T
Cancer Cell; 2017 Mar; 31(3):452-465. PubMed ID: 28292442
[TBL] [Abstract] [Full Text] [Related]
17. eto2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network.
Wheat JC; Steidl U
Cancer Cell; 2017 Mar; 31(3):307-308. PubMed ID: 28292433
[TBL] [Abstract] [Full Text] [Related]
18. AMKL chimeric transcription factors are potent inducers of leukemia.
Dang J; Nance S; Ma J; Cheng J; Walsh MP; Vogel P; Easton J; Song G; Rusch M; Gedman AL; Koss C; Downing JR; Gruber TA
Leukemia; 2017 Oct; 31(10):2228-2234. PubMed ID: 28174417
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract] [Full Text] [Related]
20. The biology of pediatric acute megakaryoblastic leukemia.
Gruber TA; Downing JR
Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939
[TBL] [Abstract] [Full Text] [Related]
[Next]
